The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, ...

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...

The beauty conglomerate has joined with biotechnology and pharmaceutical company Serpin Pharma for ingredient research.

The move forms part of ELC’s newly unveiled Beauty Reimagined strategic vision, which aims to help the company return to ...

The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be ...

Estee Lauder (EL) announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory ...

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti ...

The beauty giant is collaborating with the biotechnology and pharmaceutical company Serpin Pharma, which has been researching anti-inflammatory technologies for 20 years. The company discovered ...

(RTTNews) - Estee Lauder Companies (EL), Wednesday announced that it has partnered with biotechnology firm Serpin Pharma to explore using advanced anti-inflammatory research in skin care products.

The collaboration is set to leverage Serpin Pharma’s extensive research on anti-inflammatory processes to potentially develop new skin care products. The partnership will focus on integrating ...